DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Convergence Drivers in the Biopharmaceutical and Medical Device Industries

Biopharma-medtech convergence drivers:

1. Miniaturization and continued adoption of minimally invasive (MI) approaches

2. Continued demand and development of combination products

3. Development and approval of technology-driven, disruptive medical products

4. Evolution of the technology sector and an alignment with value-based care